Published in Hepatitis Weekly, October 18th, 1999
In this study, M. Damen and colleagues from The Netherlands' Red Cross Blood Transfusion Service evaluated a quantitative nucleic acid sequence-based amplification assay (NASBA-QT) for detection of hepatitis C virus RNA (HCV RNA). The new assay was compared with the HCV branched-DNA (bDNA) assay (Chiron Corporation) and the HCV MONITOR assay (Roche Diagnostic Systems) ("Characterization of the Quantitative HCV NASBA Assay," J Virol Methods, September 1999;82(1):45-54).
For this evaluation, five panels were designed: (1)...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.